Table 2.
Fam-STD | Controls | P-value | |
---|---|---|---|
Trans-cardiac ratio, QRS, % | 28.8 ± 13.7 | 35.7 ± 17.2 | 0.070 |
Trans-cardiac ratio, ST–T, % | 54.4 ± 22.7 | 80.6 ± 15.6 | <0.001 |
QRS 0–29 ms, direction PA | 0.156 ± 0.237 | 0.282 ± 0.176 | 0.014 |
QRS 0–29 ms, direction RL | −0.196 ± 0.469 | −0.29 ± 0.353 | 0.347 |
QRS 0–29 ms, direction AB | −0.764 ± 0.303 | −0.79 ± 0.245 | 0.518 |
QRS 30–59 ms, direction PA | −0.089 ± 0.275 | −0.109 ± 0.203 | 0.728 |
QRS 30–59 ms, direction RL | 0.825 ± 0.145 | 0.864 ± 0.143 | 0.304 |
QRS 30–59 ms, direction AB | −0.053 ± 0.473 | −0.234 ± 0.356 | 0.088 |
QRS 60–89 ms, direction PA | −0.126 ± 0.173 | −0.263 ± 0.318 | 0.001 |
QRS 60–89 ms, direction RL | 0.13 ± 0.395 | 0.413 ± 0.359 | 0.001 |
QRS 60–89 ms, direction AB | 0.865 ± 0.204 | 0.621 ± 0.386 | <0.001 |
ST 90–129 ms, direction PA | 0.006 ± 0.12 | 0.085 ± 0.396 | 0.178 |
ST 90–129 ms, direction RL | −0.461 ± 0.222 | −0.422 ± 0.45 | 0.492 |
ST 90–129 ms, direction AB | 0.806 ± 0.28 | −0.018 ± 0.681 | <0.001 |
ST 130–169 ms, direction PA | 0.031 ± 0.143 | 0.275 ± 0.224 | <0.001 |
ST 130–169 ms, direction RL | −0.523 ± 0.219 | −0.572 ± 0.287 | 0.224 |
ST 130–169 ms, direction AB | 0.762 ± 0.287 | −0.474 ± 0.494 | <0.001 |
170 ms-Tpeak, direction PA | 0.308 ± 0.334 | 0.346 ± 0.133 | 0.682 |
170 ms-Tpeak, direction RL | −0.515 ± 0.388 | −0.233 ± 0.192 | <0.001 |
170 ms-Tpeak, direction AB | 0.364 ± 0.515 | −0.873 ± 0.103 | <0.001 |
Tpeak-Tend, direction PA | 0.22 ± 0.34 | 0.22 ± 0.1 | 0.928 |
Tpeak-Tend, direction RL | 0.08 ± 0.51 | 0.16 ± 0.16 | 0.928 |
Tpeak-Tend, direction AB | −0.47 ± 0.61 | −0.94 ± 0.03 | <0.001 |
Continuous data are presented as mean ± standard deviation. Significance level set at P < 0.001 (0.05/44 = 0.001 after correction for multiple testing). Statistically significant P-values are marked in bold.
NS, non-significant.